These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10858137)

  • 1. Determining the 3D structure of HIV-1 protease.
    Kent S; Marshall GR; Wlodawer A
    Science; 2000 Jun; 288(5471):1590. PubMed ID: 10858137
    [No Abstract]   [Full Text] [Related]  

  • 2. Convergent chemical synthesis and crystal structure of a 203 amino acid "covalent dimer" HIV-1 protease enzyme molecule.
    Torbeev VY; Kent SB
    Angew Chem Int Ed Engl; 2007; 46(10):1667-70. PubMed ID: 17397076
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitor binding at the protein interface in crystals of a HIV-1 protease complex.
    Brynda J; Rezácová P; Fábry M; Horejsí M; Stouracová R; Soucek M; Hradílek M; Konvalinka J; Sedlácek J
    Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):1943-8. PubMed ID: 15502300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance.
    Hong L; Zhang XC; Hartsuck JA; Tang J
    Protein Sci; 2000 Oct; 9(10):1898-904. PubMed ID: 11106162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights from atomic-resolution X-ray structures of chemically synthesized HIV-1 protease in complex with inhibitors.
    Johnson EC; Malito E; Shen Y; Pentelute B; Rich D; Florián J; Tang WJ; Kent SB
    J Mol Biol; 2007 Oct; 373(3):573-86. PubMed ID: 17869270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between sequence and structure of HIV-1 protease inhibitor complexes: a model system for the analysis of protein flexibility.
    Zoete V; Michielin O; Karplus M
    J Mol Biol; 2002 Jan; 315(1):21-52. PubMed ID: 11771964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein conformational dynamics in the mechanism of HIV-1 protease catalysis.
    Torbeev VY; Raghuraman H; Hamelberg D; Tonelli M; Westler WM; Perozo E; Kent SB
    Proc Natl Acad Sci U S A; 2011 Dec; 108(52):20982-7. PubMed ID: 22158985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray structure of a tethered dimer for HIV-1 protease.
    Bhat TN; Baldwin ET; Liu B; Cheng YS; Erickson JW
    Adv Exp Med Biol; 1995; 362():439-44. PubMed ID: 8540354
    [No Abstract]   [Full Text] [Related]  

  • 9. Active-site mobility in human immunodeficiency virus, type 1, protease as demonstrated by crystal structure of A28S mutant.
    Hong L; Hartsuck JA; Foundling S; Ermolieff J; Tang J
    Protein Sci; 1998 Feb; 7(2):300-5. PubMed ID: 9521105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating Multiple Receptor Conformation Docking and Multi Dimensional QSAR for Enhancing Accuracy of Binding Affinity Prediction.
    Radhika V; Jaraf HA; Kanth SS; Vijjulatha M
    Curr Comput Aided Drug Des; 2017; 13(2):127-142. PubMed ID: 28103770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease.
    Chellappan S; Kairys V; Fernandes MX; Schiffer C; Gilson MK
    Proteins; 2007 Aug; 68(2):561-7. PubMed ID: 17474129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy.
    Kempf DJ; Sham HL; Marsh KC; Flentge CA; Betebenner D; Green BE; McDonald E; Vasavanonda S; Saldivar A; Wideburg NE; Kati WM; Ruiz L; Zhao C; Fino L; Patterson J; Molla A; Plattner JJ; Norbeck DW
    J Med Chem; 1998 Feb; 41(4):602-17. PubMed ID: 9484509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative fluctuations of unliganded and substrate-bound HIV-1 protease: a structure-based analysis on a variety of conformations from crystallography and molecular dynamics simulations.
    Kurt N; Scott WR; Schiffer CA; Haliloglu T
    Proteins; 2003 May; 51(3):409-22. PubMed ID: 12696052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-ray crystallographic studies of the structure-function relationships of HIV-1 protease.
    Hong L; Zhang C; Hartsuck JA; Foundling S; Tang J
    Adv Exp Med Biol; 1998; 436():59-63. PubMed ID: 9561200
    [No Abstract]   [Full Text] [Related]  

  • 15. Total chemical synthesis of a D-enzyme: the enantiomers of HIV-1 protease show reciprocal chiral substrate specificity [corrected].
    Milton RC; Milton SC; Kent SB
    Science; 1992 Jun; 256(5062):1445-8. PubMed ID: 1604320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray structure of HIV-1 protease in situ product complex.
    Bihani S; Das A; Prashar V; Ferrer JL; Hosur MV
    Proteins; 2009 Feb; 74(3):594-602. PubMed ID: 18704947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutron crystallography used to identify targets to improve HIV-1 protease inhibitor.
    Hill R
    Future Med Chem; 2013 Oct; 5(15):1705. PubMed ID: 24144407
    [No Abstract]   [Full Text] [Related]  

  • 18. Crystal structures of HIV protease V82A and L90M mutants reveal changes in the indinavir-binding site.
    Mahalingam B; Wang YF; Boross PI; Tozser J; Louis JM; Harrison RW; Weber IT
    Eur J Biochem; 2004 Apr; 271(8):1516-24. PubMed ID: 15066177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural role of the 30's loop in determining the ligand specificity of the human immunodeficiency virus protease.
    Swairjo MA; Towler EM; Debouck C; Abdel-Meguid SS
    Biochemistry; 1998 Aug; 37(31):10928-36. PubMed ID: 9692985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring inhibitor-induced conformational population shifts in HIV-1 protease by pulsed EPR spectroscopy.
    Blackburn ME; Veloro AM; Fanucci GE
    Biochemistry; 2009 Sep; 48(37):8765-7. PubMed ID: 19691291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.